BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10655466)

  • 1. Novel antimicrobial targets from combined pathogen and host genetics.
    Johnson CD; Liu LX
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):958-9. PubMed ID: 10655466
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization and comparative analysis of the EGLN gene family.
    Taylor MS
    Gene; 2001 Sep; 275(1):125-32. PubMed ID: 11574160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swietenia macrophylla extract promotes the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection.
    Dharmalingam K; Tan BK; Mahmud MZ; Sedek SA; Majid MI; Kuah MK; Sulaiman SF; Ooi KL; Khan NA; Muhammad TS; Tan MW; Shu-Chien AC
    J Ethnopharmacol; 2012 Jan; 139(2):657-63. PubMed ID: 22193176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa.
    Darby C; Cosma CL; Thomas JH; Manoil C
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15202-7. PubMed ID: 10611362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Caenorhabditis elegans and Pseudomonas aeruginosa machinery during interactions.
    Vigneshkumar B; Pandian SK; Balamurugan K
    Arch Microbiol; 2012 Apr; 194(4):229-42. PubMed ID: 21909805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors.
    Tan MW; Rahme LG; Sternberg JA; Tompkins RG; Ausubel FM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2408-13. PubMed ID: 10051655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proline Catabolism Modulates Innate Immunity in Caenorhabditis elegans.
    Tang H; Pang S
    Cell Rep; 2016 Dec; 17(11):2837-2844. PubMed ID: 27974198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caenorhabditis elegans: a model genetic host to study Pseudomonas aeruginosa pathogenesis.
    Tan MW; Ausubel FM
    Curr Opin Microbiol; 2000 Feb; 3(1):29-34. PubMed ID: 10679415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
    van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans.
    Evans EA; Kawli T; Tan MW
    PLoS Pathog; 2008 Oct; 4(10):e1000175. PubMed ID: 18927620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
    Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated whole-genome screening for Pseudomonas aeruginosa virulence genes using multiple disease models reveals that pathogenicity is host specific.
    Dubern JF; Cigana C; De Simone M; Lazenby J; Juhas M; Schwager S; Bianconi I; Döring G; Eberl L; Williams P; Bragonzi A; Cámara M
    Environ Microbiol; 2015 Nov; 17(11):4379-93. PubMed ID: 25845292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quorum-sensing systems in bacteria].
    Tateda K
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():272-9. PubMed ID: 12717983
    [No Abstract]   [Full Text] [Related]  

  • 14. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity.
    Kim DH; Feinbaum R; Alloing G; Emerson FE; Garsin DA; Inoue H; Tanaka-Hino M; Hisamoto N; Matsumoto K; Tan MW; Ausubel FM
    Science; 2002 Jul; 297(5581):623-6. PubMed ID: 12142542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C. elegans defence mechanisms].
    Ziegler K; Pujol N
    Med Sci (Paris); 2009 May; 25(5):497-503. PubMed ID: 19480831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved mitochondrial surveillance pathway is required for defense against Pseudomonas aeruginosa.
    Tjahjono E; Kirienko NV
    PLoS Genet; 2017 Jun; 13(6):e1006876. PubMed ID: 28662060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial virulence genes lead double life.
    Wuethrich B
    Science; 1995 Jun; 268(5219):1850. PubMed ID: 7604256
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans.
    Kirienko NV; Cezairliyan BO; Ausubel FM; Powell JR
    Methods Mol Biol; 2014; 1149():653-69. PubMed ID: 24818940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening for novel anti-infectives using a C. elegans pathogenesis model.
    Conery AL; Larkins-Ford J; Ausubel FM; Kirienko NV
    Curr Protoc Chem Biol; 2014 Mar; 6(1):25-37. PubMed ID: 24652621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling both sides of the host-pathogen equation with Caenorhabditis elegans.
    Ewbank JJ
    Microbes Infect; 2002 Feb; 4(2):247-56. PubMed ID: 11880058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.